1. Clinical safety of ondansetron;Bryson;Semin Oncol,1992
2. Use of QT-prolonging medications in US emergency departments, 1995-2009;Tay;Pharmacoepidemiol Drug Saf,2013
3. Ondansetron use in the pediatric emergency department and effects on hospitalization and return rates: are we masking alternative diagnoses?;Sturm;Ann Emerg Med,2010
4. Food and Drug Administration. FDA drug safety communication: abnormal heart rhythms may be associated with use of Zofran (ondansetron). Available at: http://www.fda.gov/Drugs/DrugSafety/ucm271913.htm. Accessed April 23, 2013.
5. FDA drug safety podcast for healthcare professionals: new information regarding QT prolongation with ondansetron (Zofran). Available at: http://www.fda.gov/Drugs/DrugSafety/DrugSafetyPodcasts/ucm310546.htm. Accessed September 5, 2012.